BISMARCK, N.D. (AP) -- The state of North Dakota's Medicaid program will receive about $2.9 million as part of a national settlement with drug maker Johnson & Johnson.
The state Department of Human Services says about $923,000 will go into the state's general fund and $2.07 million will go to the federal government as its share.
The Department of Justice says Johnson & Johnson promoted the powerful psychiatric drugs Risperdal and Invega for unapproved uses in children, seniors and disabled patients.
More than 66,000 low-income North Dakotans were eligible for Medicaid in November.
- Health Care Industry